3 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Selected Clinical ... in HFrEF on GDMT ... SGLT2 #inhibitors #EBM ... visualabstract #table ... #CVD #CKD
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... factors: Age>60, CKD ... , CHF, high rate ... Reactions #hematology #diagnosis ... #comparison #table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Preoperative Risk Evaluation ... disease b) CHF ... Change in clinical ... unless prior heart/lung ... stratification #diagnosis